• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN:US

119.3000 USD 2.2800 1.95%

As of 20:10:00 ET on 04/22/2014.

Company Profile for Amgen Inc (AMGN)

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Contact Information

Amgen Inc

One Amgen Center Drive
Building 27
Thousand Oaks, CA 91320-1799
United States
Phone: 1-805-447-1000
Fax: 1-805-447-1010

Key Executives for Amgen Inc (AMGN)

Robert A Bradway "Bob"Chairman/President/CEOAnthony C Hooper "Tony"Exec VP:Global Commercial Ops
Madhavan BalachandranExec VP:OperationsSean E HarperExec VP:Research & Dev
Brian M McNameeExec VP:Full Potential InitiativesDavid J ScottSenior VP/Secy/Gen Cnsl
Stuart A TrossSenior VP:Human ResourcesMartin VantriesteSenior VP:Quality
Michael A KellyVP:Intl Finance/Acting CFOThomas J W DittrichVP:Finance/Chief Acctg Officer
Arvind SoodVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil